S
Sol Gel Technologies Ltd (SLGL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$54.96
-0.16 (-0.29%)
Market Cap: $180.46M
Last updated: Nov 17, 2026 at 11:06 AM ET
Sol Gel Technologies Ltd (SLGL) Valuation Multiples
Sol Gel Technologies (SLGL) trades at 125.4x sales and 4.2x book value. Its P/S of 125.4x is above its 5-year median of 13.5x. Its forward P/E is 9.3x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 9.3x |
| Price to sales | 125.4x |
| Price to book | 4.2x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 50.0% above 2.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 125.4x | 13.5x | N/A |
| P/B | 4.2x | 2.4x | 2.8x |
Valuation History
Over the 8 year ends shown, its P/S ranged from 2.2x in 2024 to 801.0x in 2018.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $42.14 | 54.7x | 6.4x | 5.1x |
| 2024 | $9.30 | 25.8x | 2.2x | 0.9x |
| 2023 | $11.05 | N/A | 14.6x | 0.8x |
| 2022 | $45.60 | N/A | 27.8x | 25.0x |
| 2021 | $74.00 | N/A | 13.9x | 31.5x |
| 2020 | $97.90 | N/A | 31.3x | 44.3x |
| 2019 | $171.50 | N/A | 24.4x | 69.8x |
| 2018 | $60.20 | N/A | 801.0x | 1.8x |
Frequently Asked Questions About SLGL
What is SLGL's forward P/E ratio?
Sol Gel Technologies has a forward P/E ratio of 9.3x.
What is SLGL's price to sales ratio?
Sol Gel Technologies has a price to sales ratio of 125.4x.
SLGL pages: Overview, Earnings, Forecast, Valuation, Competitors